Cargando…
Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability
Cardiotoxicity induced by anti-cancer therapeutics is a severe, and potentially fatal, adverse reaction of the heart in response to certain drugs. Current in vitro approaches to assess cardiotoxicity have focused on analysing cardiomyocytes. More recently it has become apparent that non-cardiomyocyt...
Autores principales: | Wilkinson, Emma L., Sidaway, James E., Cross, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087671/ https://www.ncbi.nlm.nih.gov/pubmed/27543060 http://dx.doi.org/10.1242/bio.020362 |
Ejemplares similares
-
Statin regulated ERK5 stimulates tight junction formation and reduces permeability in human cardiac endothelial cells
por: Wilkinson, Emma L., et al.
Publicado: (2017) -
Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance
por: Jiang, Jin, et al.
Publicado: (2022) -
Barrier stabilizing mediators in regulation of microvascular endothelial permeability
por: Qiao-bing, Huang, et al.
Publicado: (2012) -
Delineation of anthracyclines and herceptin induced cardiotoxicity using contrast enhanced CMR
por: Hamirani, Yasmin S, et al.
Publicado: (2014) -
A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
por: Heger, Zbynek, et al.
Publicado: (2013)